ArticleJournal of clinical and experimental hepatology2012
Non-alcoholic Fatty Liver Disease: East Versus West.
Article in Journal of clinical and experimental hepatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments.Current issues in molecular biology · 2025Article
- The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the West.Frontiers in gastroenterology (Lausanne, Switzerland) · 2025Review
- Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.Canadian liver journal · 2024Article
- Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019Article
- Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019Review
- A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.Journal of clinical and experimental hepatology · 2018Article
- Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2017Article
- Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature.Journal of clinical and translational hepatology · 2017Review
- Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study.F1000Research · 2017Article
- Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?Inflammatory intestinal diseases · 2016Article
- Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.International journal of organ transplantation medicine · 2016Review
- Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.PloS one · 2016Article
- Editor-in-Chief's welcome toHepatology, medicine and policy · 2016Article
- Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center.Hepatology international · 2015Article
- Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review.SpringerPlus · 2015Article
- Hepatobiliary quiz-10 (2014).Journal of clinical and experimental hepatology · 2014Article
- Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.Hepatology international · 2013Article
- Hepatobiliary quiz-7 (2013).Journal of clinical and experimental hepatology · 2013Article
- Hepatobiliary quiz-6 (2013).Journal of clinical and experimental hepatology · 2013Article
- Hepatobiliary quiz-3 (2012).Journal of clinical and experimental hepatology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an important cause of liver disease worldwide with prevalence ranging from 10% to 30% in various countries. It has become an important cause of unexplained rise in transaminases, cryptogenic cirrhosis, and cryptogenic hepatocellular carcinoma. Pathogenesis is related to obesity, insulin resistance, oxidative stress, lipotoxicity, and resultant inflammation in the liver progressing to fibrosis. Pharmacological treatment in patients with NAFLD is still evolving and the treatment of these patients rests upon lifestyle modification with diet and exercise being the cornerstones of therapy. While there are many similarities between patients with NAFLD from Asia and the West, there are certain features which make the patients with NAFLD from Asia stand apart. This review highlights the data on NAFLD from Asia comparing it with the data from the West.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.